Le Sante
OPHTHALMOLOGY
RANGE

Antimigrane

Anti-Infectives

Anti-Infectives

Anti-Inflammatories

Mydriatics and Cycloplegics
ADDRESS
Cadila Pharmaceuticals Limited
"Cadila
Corporate Campus"
Sarkhej-Dholka Road,
Bhat, Ahmedabad-382 210, INDIA.
Phone : +91-2718-225001 (15 Lines)
Fax :+91-2718-225039
e-mail :
website@cadilapharma.co.in
CLICK
HERE FOR THE LATEST ONLINE UPDATES OF
TOP |
Le Sante
|
Product |
Therapeutic Cat. |
Active Ingredients |
Formulations |
Indications |
Usual
dosage |
|
ANTI- ACNE
|
|
Alene
Gel
|
Anti-Acne gel
(Dermatology) |
Adapalene
(Topical Retinoid) |
Adapalene gel 0.1%
15 gm tube |
For topical
application once daily in mild to moderate acne vulgaris,
|
To be applied once
daily over the affected areas and the surrounding normal areas as
well in the evening or at bedtime as a thin layer
|

Anti-Allergics / Anti-Histaminics
|
Product |
Therapeutic Cat. |
Active Ingredients |
Formulations |
Indications |
Usual
dosage |
ANTI-ALLERGICS /
ANTI-HISTAMINICS
|
Des-OD TAB
|
Antihistamine,
anti-inflammatory and decongestant |
Desloratadine |
Tablet
5 mg |
Allergic Rhinitis,
Chronic Urticaria,
Mild to moderate
asthma with associated allergic rhinitis |
One tablet daily |
Lorfast TAB
|
Antihistamine |
Loratadine |
Tablet
10 mg |
Allergic rhinitis,
Atopic Dermatitis, Common skin allergies |
One tablet daily |
Lorfast-D TAB
|
Antihistamine and
nasal decongestant combination |
Loratadine +
Pseudoephedrine hydrochloride |
Tablet
5 mg + 120
mg |
Seasonal allergic
rhinitis with nasal congestion |
1 tablet twice
daily |
|
Product |
Therapeutic Cat. |
Active Ingredients |
Formulations |
Indications |
Usual
dosage |
ANTI-INFLAMMATORIES
(NON-STEROIDAL)
|
Nilide TAB
|
Non-steroidal
anti-inflammatory (COX-2 inhibitor) |
Nimesulide |
Tablet
100 mg |
Osteoarthritis and
other musculoskeletal disorders, dysmenorrhoea, fever and
inflammation accompanying RTI, ENT infections and surgery |
100 mg twice daily |
Nilide Gel
|
Non-steroidal
anti-inflammatory (COX-2 inhibitor) |
Nimesulide |
Gel
10mg /g |
Osteoarthritis,
periarthritis, post-traumatic or acute musculoskeletal; disorders
including tendinitis, tenosynovitis, sprains, strains and low back
pain |
Apply to the
affected site 3 to 4 times daily |
|
Product |
Therapeutic Cat. |
Active Ingredients |
Formulations |
Indications |
Usual
dosage |
ANTIMIGRAINE
|
Migon
TAB
|
Antimigraine |
Flunarizine
hydrochloride |
Tablet
10 mg |
Prophylaxis of
migraine |
One tablet in a day
in the evening |
Vasograin TAB
|
Antimigraine |
Ergotamine tartrate
+ Prochlorperazine maleate + Caffeine + Paracetamol |
Tablet
1mg + 2.5mg
+ 100mg + 250mg |
Treatment of
migraine |
1 to 2 tablets at
the start of attack, followed by additional 1 to 2 tablets at
intervals of at least 30 minutes upto maximum 6 tablets per day |
|
Product |
Therapeutic Cat. |
Active Ingredients |
Formulations |
Indications |
Usual
dosage |
ANTI-AIDS
(ANTI-RETROVIRAL THERAPY)
|
Zilion TAB
|
Anti-retroviral
agent;
anti-AIDS |
Zidovudine
(nucleoside reverse
transcriptase inhibitor)
nRTI |
Tablet
300 mg |
HIV Infection
and AIDS |
In HIV infection
and AIDS:
300 mg twice daily
In HIV infected
pregnant women:
300 mg twice daily
from 14th to 34th week of pregnancy inorder to
prevent and/or reduce mother to child transmission |
Lamda TAB
|
Anti-retroviral
agent;
anti-AIDS |
Lamivudine
(nucleoside reverse
transcriptase inhibitor)
nRTI |
Tablet
150 mg |
HIV Infection
and AIDS |
In HIV infection
and AIDS:
150 mg twice daily,
usually along with other antiretroviral agent (s) |
Lamda –Z TAB
|
Anti-retroviral
agent;
anti-AIDS |
Lamivudine plus
zidovudine |
Lamivudine
150 mg
plus Zidovudine 300 mg combination pill |
HIV Infection
and AIDS |
In HIV infection
and AIDS:
1 tablet twice
daily, part of combination regimens with nnRTI’s such as Neve and
Protease inhibitors such as nelfinavir and indinavir |
Neve
TAB
|
Anti-retroviral
agent;
anti-AIDS |
Nevirapine
(non-nucleoside
reverse transcriptase inhibitor)
nnRTI |
Tablet
200 mg |
HIV Infection
and AIDS |
In HIV infection
and AIDS:
200 mg once
daily for two weeks, followed by 200 mg twice daily, usually used
with one other antiretroviral agent
In HIV infected
pregnant women:
Single dose 200
mg at the time of labour
in order to prevent and/or reduce mother to child
transmission of HIV, provides an economic alternative in late
pregnancy
|
|
Product |
Therapeutic Cat. |
Active Ingredients |
Formulations |
Indications |
Usual
dosage |
DIETARY SUPPLEMENTS
(AMINO ACIDS AND VITAMINS)
|
Emvit
CAP
|
Dietary supplement
of amino acids and vitamins |
L-leucine 18.3 mg
L-isoleucine 5.9 mg
L-lysine hydrochloride 25 mg
L-phenylalanine 5 mg
L-threonine 4.2 mg
L-valine 6.7 mg
L-tryptophan
5 mg DL-methionine
18.4 mg
5-hydroxyanthranilic acid hydrochloride
0.2 mg
Vitamin A concentrate 2500 I.U.
Thiamine mononitrate 4.5 mg Riboflavin 3.5 mg
Nicotinamide 25 mg Pyridoxine hydrochloride
3.5
mg Folic acid 0.5 mg Calcium pantothenate 5 mg
Cyanocobalamin
2.5 mcg
Ascorbic acid 41 mg Cholecalciferol
200 I. U.
Topopheryl acetate 7.5 I. U. |
Capsule |
Dietary supplement
in conditions like hypopro-
teinemia, pre- and post- operative states, chemotherapy, pregnancy
and lactation, prolonged illness, convale-
scense and in geriatric patients |
1 capsule twice
daily |
Paediatric Range
|
Product |
Therapeutic Cat. |
Active Ingredients |
Formulations |
Indications |
Usual dosage L |
VACCINES
|
Typhim VI Pre-filled Syringe
|
Typhoid
vaccine |
Purified Vi
capsular polysaccharide of S. Typhi |
prefilled
syringe, containing
0.025 mg in
0.5 ml buffered solution. |
Prevention
of Typhoid fever |
Single IM or
SE injection into the deltoid area or anterolateral aspect of
thigh |
|
Product |
Therapeutic Cat. |
Active Ingredients |
Formulations |
Indications |
Usual dosage |
ANTI-INFECTIVES
|
Roxibid-50 DT
|
Antibiotic (Macrolide) |
Roxith-
romycin |
Dispersible
tablet
50 mg |
ENT
infections, lower RTI, skin and soft tissue infections |
5 to 8
mg/kg/day in 2 divided doses 30 minutes before meals |
Wormin-A
|
Anthelmentic |
Albendazole |
Tablet
400
mg
Suspension
200mg/5ml |
Ascariasis,
Ancyclo-
stomiasis, Enterobiasis, Strongy-
loidiasis, Trichuriasis, Taeniasis, Enchino-
coccosis |
Ascariasis,
Ancyclo-
stomiasis, Enterobiasis, Trichuriasis: 400 mg single dose Strongy-
loidiasis,
and Taeniasis: 400 mg Neurocya-
sticercosis: 15 mg/kg/day for 28 days cycles with a 1 week
drug-free interval |
Ophthalmology Range
|
Product |
Therapeutic Cat. |
Active Ingredients |
Formulations |
Indications |
Usual dosage L |
ANTI-INFECTIVES / ANTI-INFLAMMATORY
|
Obrasone Eye Drops
|
Antibiotic
(Amino-
glycoside) and steroidal anti-
inflammatory |
Tobra-
mycin (as sulphate) + Dexame-
thasone sodium phosphate + Benzal-
konium chloride |
Eye drops
0.3% w/v + 0.1% w/v + 0.01% w/v |
Inflammatory
conditions of teh palpebral and bulbar conjuctiva, chronic
anterior uveitis and corneal injury due to chemical, radiation or
thermal burns, or penetration of foreign bodies. |
1-2 drops in
conjuctival sac every 406 hours initially within 48 hours, may be
increased to 1-2 drops every 2 hours |
|
Product |
Therapeutic Cat. |
Active Ingredients |
Formulations |
Indications |
Usual dosage L |
ANTI-INFLAMMATORIES (STEROIDAL, NON-STEROIDAL)
|
Cadiflur Eye drops
|
Non-steroidal, anti-inflammatory |
Flubiprofen |
Eye drops
0.03% |
Inhibition
of intrao-
perative miosis and inflammation of the eye. |
Inhibition
of intrao-
perative miosis: 1 drop every 1/2 an hour beginning 2 hours before
surgery. Inflammation: 1 drop 4 times a day. |
|
Product |
Therapeutic Cat. |
Active Ingredients |
Formulations |
Indications |
Usual dosage L |
MYDRIATICS AND CYCLOPLEGICS
|
Cyclate Eye Drops
|
Anticho-
linergic |
Cyclo-
pentolate hydrochloride |
Eye drops
1% |
Induction of
mydriasis and cyclolegia for diagnostic purposes. |
1-2 drops as
required |
Tmide Eye Drops
|
Anticho-
linergic |
Tropicamide |
Eye drops
1% |
Induction of
mydriasis and cyclolegia |
1-2 drops at
1-5 min. intervals
|
|
Product |
Therapeutic Cat. |
Active Ingredients |
Formulations |
Indications |
Usual dosage L |
ANTIGLAUCOMA AGENTS
|
Locarp Eye Drops
|
Miotic |
Pilocarpine
nitrate |
Eye drops
2% |
Chronic open
angle glaucoma; to produce miosis after pupilliary dilation with
mydriatic, to break the adhesion between iris and lens along with
mydriatics. |
1 to 2 drops
every 4 to 12 hours. |
Locarp Gel
|
Miotic |
Pilocarpine
nitrate |
Ophthalmic gel
4% |
Chronic open
angle glaucoma for control of IOP as monotherapy or in patients who
respond inadequately to other drugs |
Initially 15mm
ribbon applied in conjunctival sac of eye once a day at bed time. In
newly diagnosed cases, initial treatment with low concentration of
pilocarpine drops before Locarp gel therapy. |
|
Product |
Therapeutic Cat. |
Active Ingredients |
Formulations |
Indications |
Usual dosage L |
MISCELLANEOUS : ANTI-OXIDANT
|
Ocuvit CAP
|
Antioxidant |
Vitamin E
acetate + Vitamin C |
Capsule
200
mg +
150 mg |
Prevention of
free oxygen radical-induced diseases |
1 or 2
capsules per day |
|
Product |
Therapeutic Cat. |
Active Ingredients |
Formulations |
Indications |
Usual dosage L |
VISCOELASTICS / OCULAR LUBRICANT
|
Visial Pre-filled syringe
|
Viscoelastic |
Sodium
hyaluronate 1% w/v |
Prefilled
syringe containing 0.8 ml in buffered solution |
Adjuct in eye
surgery, in cataract extraction, keratoplaty, trabeculectomy,
anterior segment wound repair, preretinal membrane dissection,
surgery for retinal detachment |
Inject through
the fine cannula into the eye. Repeated injections may be required. |
Sanvisc inj.
|
Ocular
lubricant |
Hydro-
xypropyl methy-
lcellulose |
Injection
2%
solution |
Opthalmic
procedures of teh anterior segment, cataract surgery with
Intraocular lens implantation, during keratoplasty and filtering
operations for glaucoma |
Slowly
introduce solution in anterior chamber using a cannula. |
|
BACK |